Therefore, the fact that DOT1L-deletion rendered a highly aggressive TP53 mutant blast-phase MPN model sensitive to LSD1 inhibition causing growth arrest and even induction of apoptosis is remarkable and demands further preclinical exploration. The gene discussed is TP53; the disease is myeloproliferative neoplasm.